Bringing you just the headlines

  • James Anderson has earned the right to be judged on more than one three-over spell

    At some stage, all those overs, all those miles, all those long spells are going to show
  • No Dining Out Right Now

    Eater food critic Ryan Sutton, who had Covid-19 back in March, isn’t dining out at restaurants right now and explains why. What’s more is that local health regulations for dining out aren’t strong enough. Before every shift, restaurants have to screen employees with health based questions, but temperature checks aren’t mandatory for either staffers or employees. And even though patrons are encouraged to wear masks at tables while they’re not actively eating or drinking, few really do. Even if...
  • NVIDIA in advanced talks to buy ARM

    To continue, please click the box below to let us know you're not a robot.
  • 5 Booming Biotech Stocks to Buy

    You could say biotechnology companies' shares were merely "interrupted" this year. Biotech stocks, as measured by the iShares Nasdaq Biotechnology ETF (IBB), started to rally furiously in the back half of 2019. The COVID-sparked market downturn knocked them down, but they've returned to outperformance and are now up 15% year-to-date. The party likely isn't over, either. New markets in areas such as anti-aging therapies and gene editing could be worth billions of dollars over the coming decade....